🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tom T. Shimabukuro

Centers for Disease Control and Prevention

ORCID: 0000-0002-1357-0219

Also affiliated with National Center for Immunization and Respiratory Diseases

Social SciencesMedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Human infections with highly pathogenic avian influenza A(H5N1) viruses in the United States from March 2024 to May 2025”.

Human infections with highly pathogenic avian influenza A(H5N1) viruses in the United States from March 2024 to May 2025

Nature Medicine(2025)10.1038/s41591-025-03905-2
N/A
1.5DataRank · unranked
38 citations

Krista Kniss, Marie K. Kirby, Shikha Garg, Katie Reinhart, C. Todd Davis +75 more

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021

JAMA(2021)10.1001/jama.2021.1967
N/A
0.929DataRank · unranked
489 citations

Matt Cole, John R. Su, Tom T. Shimabukuro

Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study

The Lancet Child & Adolescent Health(2022)10.1016/s2352-4642(22)00244-9
N/A
0.655DataRank · unranked
78 citations

Matthew E. Oster, Karen R. Broder, Margaret M. Cortese, Maleeka Glover, Karen L. Shields +73 more

Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years

PEDIATRICS(2022)10.1542/peds.2022-057313
N/A
0.628DataRank · unranked
65 citations

David K. Shay, Nicola P. Klein, Winston E. Abara, James Baggs, Margaret M. Cortese +25 more

COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic

Vaccine(2024)10.1016/j.vaccine.2023.12.059
N/A
0.466DataRank · unranked
13 citations

Robert Hopkins, Karen R. Broder, Grace M. Lee, Kathryn M. Edwards, Matthew F. Daley +23 more

Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic

Vaccine(2024)10.1016/j.vaccine.2024.01.069
N/A
0.330DataRank · unranked
8 citations

Sarah Carroll, Kara N.D. Polen, Tara C. Jatlaoui, Sarah Meyer, Sara E. Oliver +10 more

COVID-19 Vaccine Safety First Year Findings in Adolescents

PEDIATRICS(2023)10.1542/peds.2022-060295
N/A
0DataRank · unranked
16 citations

Anne M. Hause, Tanya R. Myers, John R. Su, Paige Marquez, Bicheng Zhang +13 more

Outbreak of Highly Pathogenic Avian Influenza A(H5N1) Viruses in U.S. Dairy Cattle and Detection of Two Human Cases — United States, 2024

MMWR Morbidity and Mortality Weekly Report(2024)10.15585/mmwr.mm7321e1
N/A
0DataRank · unranked
128 citations

Carrie Reed, C. Todd Davis, Timothy M. Uyeki, Casey Barton Behravesh, Krista Kniss +18 more

Tinnitus after COVID-19 vaccination: Findings from the vaccine adverse event reporting system and the vaccine safety datalink

American Journal of Otolaryngology(2024)10.1016/j.amjoto.2024.104448
N/A
0DataRank · unranked
7 citations

Jonathan Duffy, John R. Su, Samaneh Bazel, Bruce Fireman, Laura P. Hurley +12 more

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

MMWR Morbidity and Mortality Weekly Report(2021)10.15585/mmwr.mm7027e2
N/A
0DataRank · unranked
602 citations

Megan Wallace, Stephen C. Hadler, Gayle Langley, John R. Su, Matthew E. Oster +15 more

Clinical immunization safety assessment (CISA) project: COVID-19 vaccine consultations and case reviews

Vaccine(2025)10.1016/j.vaccine.2025.127781
N/A
0DataRank · unranked
1 citations

Gabriella Ess, Allison Lale, Kawsar R. Talaat, Elizabeth D. Barnett, Stephen I. Pelton +17 more

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

JAMA(2021)10.1001/jama.2021.0600
N/A
0DataRank · unranked
333 citations

Narayan Nair, Tom T. Shimabukuro

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021

MMWR Morbidity and Mortality Weekly Report(2021)10.15585/mmwr.mm7032e4
N/A
0DataRank · unranked
215 citations

Stephen C. Hadler, Danielle Moulia, Tom T. Shimabukuro, John R. Su, Naomi K. Tepper +17 more

Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7103a4
N/A
0DataRank · unranked
101 citations

Megan Wallace, Isaac See, Sarah Mbaeyi, Monica Godfrey, Stephen C. Hadler +19 more

Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose

Archives of Pathology & Laboratory Medicine(2022)10.5858/arpa.2022-0084-le
N/A
0DataRank · unranked
3 citations

Sarah Reagan-Steiner, John R. Su, Matthew E. Oster, Roosecelis B. Martines, Julu Bhatnagar +2 more

A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States

Vaccine(2023)10.1016/j.vaccine.2023.07.037
N/A
0DataRank · unranked
21 citations

Hannah G. Rosenblum, Danielle Moulia, Karen R. Broder, Tom T. Shimabukuro, Christopher A. Taylor +7 more